nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—Esomeprazole—Barrett's esophagus	0.266	0.389	CbGbCtD
Rivaroxaban—ABCB1—Omeprazole—Barrett's esophagus	0.261	0.382	CbGbCtD
Rivaroxaban—CYP3A4—Omeprazole—Barrett's esophagus	0.157	0.229	CbGbCtD
Rivaroxaban—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00443	0.0154	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00443	0.0154	CcSEcCtD
Rivaroxaban—Swelling—Omeprazole—Barrett's esophagus	0.00439	0.0153	CcSEcCtD
Rivaroxaban—Swelling—Esomeprazole—Barrett's esophagus	0.00439	0.0153	CcSEcCtD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00392	0.136	CbGpPWpGaD
Rivaroxaban—Pain in extremity—Omeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00387	0.0135	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00363	0.0126	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00363	0.0126	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00353	0.0123	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00353	0.0123	CcSEcCtD
Rivaroxaban—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00326	0.0113	CcSEcCtD
Rivaroxaban—Angina pectoris—Omeprazole—Barrett's esophagus	0.00326	0.0113	CcSEcCtD
Rivaroxaban—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00298	0.0104	CcSEcCtD
Rivaroxaban—Infestation—Esomeprazole—Barrett's esophagus	0.00298	0.0104	CcSEcCtD
Rivaroxaban—Infestation NOS—Omeprazole—Barrett's esophagus	0.00298	0.0104	CcSEcCtD
Rivaroxaban—Infestation—Omeprazole—Barrett's esophagus	0.00298	0.0104	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00296	0.0103	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00296	0.0103	CcSEcCtD
Rivaroxaban—Renal failure—Esomeprazole—Barrett's esophagus	0.00293	0.0102	CcSEcCtD
Rivaroxaban—Renal failure—Omeprazole—Barrett's esophagus	0.00293	0.0102	CcSEcCtD
Rivaroxaban—Jaundice—Esomeprazole—Barrett's esophagus	0.00291	0.0101	CcSEcCtD
Rivaroxaban—Jaundice—Omeprazole—Barrett's esophagus	0.00291	0.0101	CcSEcCtD
Rivaroxaban—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0029	0.0101	CcSEcCtD
Rivaroxaban—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0029	0.0101	CcSEcCtD
Rivaroxaban—Haematuria—Esomeprazole—Barrett's esophagus	0.00284	0.00989	CcSEcCtD
Rivaroxaban—Haematuria—Omeprazole—Barrett's esophagus	0.00284	0.00989	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00282	0.00981	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00282	0.00981	CcSEcCtD
Rivaroxaban—Epistaxis—Esomeprazole—Barrett's esophagus	0.00281	0.00979	CcSEcCtD
Rivaroxaban—Epistaxis—Omeprazole—Barrett's esophagus	0.00281	0.00979	CcSEcCtD
Rivaroxaban—Sinusitis—Omeprazole—Barrett's esophagus	0.0028	0.00973	CcSEcCtD
Rivaroxaban—Sinusitis—Esomeprazole—Barrett's esophagus	0.0028	0.00973	CcSEcCtD
Rivaroxaban—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00278	0.00968	CcSEcCtD
Rivaroxaban—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00278	0.00968	CcSEcCtD
Rivaroxaban—Hepatitis—Esomeprazole—Barrett's esophagus	0.00268	0.00931	CcSEcCtD
Rivaroxaban—Hepatitis—Omeprazole—Barrett's esophagus	0.00268	0.00931	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00264	0.0092	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00264	0.0092	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00263	0.00915	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00263	0.00915	CcSEcCtD
Rivaroxaban—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00262	0.00913	CcSEcCtD
Rivaroxaban—Urethral disorder—Omeprazole—Barrett's esophagus	0.00262	0.00913	CcSEcCtD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00257	0.0893	CbGpPWpGaD
Rivaroxaban—CYP2J2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00253	0.0881	CbGpPWpGaD
Rivaroxaban—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00253	0.00881	CcSEcCtD
Rivaroxaban—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00253	0.00881	CcSEcCtD
Rivaroxaban—Eye disorder—Omeprazole—Barrett's esophagus	0.0025	0.0087	CcSEcCtD
Rivaroxaban—Eye disorder—Esomeprazole—Barrett's esophagus	0.0025	0.0087	CcSEcCtD
Rivaroxaban—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00242	0.00841	CcSEcCtD
Rivaroxaban—Immune system disorder—Omeprazole—Barrett's esophagus	0.00242	0.00841	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00241	0.00839	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00241	0.00839	CcSEcCtD
Rivaroxaban—Back pain—Omeprazole—Barrett's esophagus	0.00225	0.00784	CcSEcCtD
Rivaroxaban—Back pain—Esomeprazole—Barrett's esophagus	0.00225	0.00784	CcSEcCtD
Rivaroxaban—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00224	0.0078	CcSEcCtD
Rivaroxaban—Muscle spasms—Omeprazole—Barrett's esophagus	0.00224	0.0078	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00216	0.00752	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00216	0.00752	CcSEcCtD
Rivaroxaban—Anaemia—Omeprazole—Barrett's esophagus	0.00215	0.00749	CcSEcCtD
Rivaroxaban—Anaemia—Esomeprazole—Barrett's esophagus	0.00215	0.00749	CcSEcCtD
Rivaroxaban—Angioedema—Esomeprazole—Barrett's esophagus	0.00213	0.00741	CcSEcCtD
Rivaroxaban—Angioedema—Omeprazole—Barrett's esophagus	0.00213	0.00741	CcSEcCtD
Rivaroxaban—Malaise—Omeprazole—Barrett's esophagus	0.0021	0.00731	CcSEcCtD
Rivaroxaban—Malaise—Esomeprazole—Barrett's esophagus	0.0021	0.00731	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00208	0.0724	CbGpPWpGaD
Rivaroxaban—Chest pain—Omeprazole—Barrett's esophagus	0.00198	0.0069	CcSEcCtD
Rivaroxaban—Chest pain—Esomeprazole—Barrett's esophagus	0.00198	0.0069	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00197	0.00686	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00197	0.00686	CcSEcCtD
Rivaroxaban—Discomfort—Omeprazole—Barrett's esophagus	0.00196	0.00682	CcSEcCtD
Rivaroxaban—Discomfort—Esomeprazole—Barrett's esophagus	0.00196	0.00682	CcSEcCtD
Rivaroxaban—Dry mouth—Omeprazole—Barrett's esophagus	0.00194	0.00675	CcSEcCtD
Rivaroxaban—Dry mouth—Esomeprazole—Barrett's esophagus	0.00194	0.00675	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.0019	0.00662	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.0019	0.00662	CcSEcCtD
Rivaroxaban—Infection—Esomeprazole—Barrett's esophagus	0.00189	0.00657	CcSEcCtD
Rivaroxaban—Infection—Omeprazole—Barrett's esophagus	0.00189	0.00657	CcSEcCtD
Rivaroxaban—Shock—Omeprazole—Barrett's esophagus	0.00187	0.00651	CcSEcCtD
Rivaroxaban—Shock—Esomeprazole—Barrett's esophagus	0.00187	0.00651	CcSEcCtD
Rivaroxaban—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00187	0.00649	CcSEcCtD
Rivaroxaban—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00187	0.00649	CcSEcCtD
Rivaroxaban—Tachycardia—Esomeprazole—Barrett's esophagus	0.00186	0.00646	CcSEcCtD
Rivaroxaban—Tachycardia—Omeprazole—Barrett's esophagus	0.00186	0.00646	CcSEcCtD
Rivaroxaban—Skin disorder—Esomeprazole—Barrett's esophagus	0.00185	0.00643	CcSEcCtD
Rivaroxaban—Skin disorder—Omeprazole—Barrett's esophagus	0.00185	0.00643	CcSEcCtD
Rivaroxaban—Dyspnoea—Esomeprazole—Barrett's esophagus	0.0017	0.0059	CcSEcCtD
Rivaroxaban—Dyspnoea—Omeprazole—Barrett's esophagus	0.0017	0.0059	CcSEcCtD
Rivaroxaban—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00167	0.00582	CcSEcCtD
Rivaroxaban—Dyspepsia—Omeprazole—Barrett's esophagus	0.00167	0.00582	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00164	0.00571	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00164	0.00571	CcSEcCtD
Rivaroxaban—Fatigue—Esomeprazole—Barrett's esophagus	0.00164	0.00571	CcSEcCtD
Rivaroxaban—Fatigue—Omeprazole—Barrett's esophagus	0.00164	0.00571	CcSEcCtD
Rivaroxaban—Constipation—Omeprazole—Barrett's esophagus	0.00163	0.00566	CcSEcCtD
Rivaroxaban—Pain—Esomeprazole—Barrett's esophagus	0.00163	0.00566	CcSEcCtD
Rivaroxaban—Constipation—Esomeprazole—Barrett's esophagus	0.00163	0.00566	CcSEcCtD
Rivaroxaban—Pain—Omeprazole—Barrett's esophagus	0.00163	0.00566	CcSEcCtD
Rivaroxaban—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00157	0.00545	CcSEcCtD
Rivaroxaban—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00157	0.00545	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00156	0.00541	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00156	0.00541	CcSEcCtD
Rivaroxaban—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00153	0.0532	CbGpPWpGaD
Rivaroxaban—Urticaria—Esomeprazole—Barrett's esophagus	0.00151	0.00526	CcSEcCtD
Rivaroxaban—Urticaria—Omeprazole—Barrett's esophagus	0.00151	0.00526	CcSEcCtD
Rivaroxaban—Abdominal pain—Esomeprazole—Barrett's esophagus	0.0015	0.00523	CcSEcCtD
Rivaroxaban—Abdominal pain—Omeprazole—Barrett's esophagus	0.0015	0.00523	CcSEcCtD
Rivaroxaban—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.0014	0.00488	CcSEcCtD
Rivaroxaban—Hypersensitivity—Omeprazole—Barrett's esophagus	0.0014	0.00488	CcSEcCtD
Rivaroxaban—Asthenia—Omeprazole—Barrett's esophagus	0.00136	0.00475	CcSEcCtD
Rivaroxaban—Asthenia—Esomeprazole—Barrett's esophagus	0.00136	0.00475	CcSEcCtD
Rivaroxaban—Pruritus—Esomeprazole—Barrett's esophagus	0.00135	0.00468	CcSEcCtD
Rivaroxaban—Pruritus—Omeprazole—Barrett's esophagus	0.00135	0.00468	CcSEcCtD
Rivaroxaban—Diarrhoea—Esomeprazole—Barrett's esophagus	0.0013	0.00453	CcSEcCtD
Rivaroxaban—Diarrhoea—Omeprazole—Barrett's esophagus	0.0013	0.00453	CcSEcCtD
Rivaroxaban—Dizziness—Esomeprazole—Barrett's esophagus	0.00126	0.00438	CcSEcCtD
Rivaroxaban—Dizziness—Omeprazole—Barrett's esophagus	0.00126	0.00438	CcSEcCtD
Rivaroxaban—Vomiting—Omeprazole—Barrett's esophagus	0.00121	0.00421	CcSEcCtD
Rivaroxaban—Vomiting—Esomeprazole—Barrett's esophagus	0.00121	0.00421	CcSEcCtD
Rivaroxaban—Rash—Esomeprazole—Barrett's esophagus	0.0012	0.00417	CcSEcCtD
Rivaroxaban—Rash—Omeprazole—Barrett's esophagus	0.0012	0.00417	CcSEcCtD
Rivaroxaban—Dermatitis—Omeprazole—Barrett's esophagus	0.0012	0.00417	CcSEcCtD
Rivaroxaban—Dermatitis—Esomeprazole—Barrett's esophagus	0.0012	0.00417	CcSEcCtD
Rivaroxaban—Headache—Omeprazole—Barrett's esophagus	0.00119	0.00415	CcSEcCtD
Rivaroxaban—Headache—Esomeprazole—Barrett's esophagus	0.00119	0.00415	CcSEcCtD
Rivaroxaban—Nausea—Esomeprazole—Barrett's esophagus	0.00113	0.00393	CcSEcCtD
Rivaroxaban—Nausea—Omeprazole—Barrett's esophagus	0.00113	0.00393	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—CYP26A1—Barrett's esophagus	0.00111	0.0384	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00109	0.0379	CbGpPWpGaD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000944	0.0328	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00088	0.0306	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00088	0.0306	CbGpPWpGaD
Rivaroxaban—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000809	0.0281	CbGpPWpGaD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000769	0.0267	CbGpPWpGaD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00074	0.0257	CbGpPWpGaD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000731	0.0254	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.0006	0.0209	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000566	0.0197	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00056	0.0195	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000542	0.0188	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000542	0.0188	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CDX2—Barrett's esophagus	0.000438	0.0152	CbGpPWpGaD
Rivaroxaban—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000376	0.0131	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000344	0.012	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00034	0.0118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000319	0.0111	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000314	0.0109	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00029	0.0101	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000279	0.0097	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGES—Barrett's esophagus	0.00025	0.00867	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HGF—Barrett's esophagus	0.000218	0.00756	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP26A1—Barrett's esophagus	0.000189	0.00657	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000178	0.0062	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000148	0.00515	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000146	0.00508	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.00014	0.00486	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—SLC9A1—Barrett's esophagus	0.000136	0.00474	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000113	0.00391	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.00011	0.00382	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000103	0.00359	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—Barrett's esophagus	9.36e-05	0.00325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	7.54e-05	0.00262	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—Barrett's esophagus	7.3e-05	0.00254	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGES—Barrett's esophagus	7.19e-05	0.0025	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.33e-05	0.0022	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—Barrett's esophagus	6.22e-05	0.00216	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	5.73e-05	0.00199	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	5.45e-05	0.00189	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGES—Barrett's esophagus	5.43e-05	0.00189	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—Barrett's esophagus	4.9e-05	0.0017	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.11e-05	0.00143	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	3.93e-05	0.00137	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.41e-05	0.00118	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.34e-05	0.00116	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.97e-05	0.00103	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.53e-05	0.000881	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.83e-05	0.000635	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.79e-05	0.000623	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.41e-05	0.00049	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.35e-05	0.00047	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.06e-05	0.00037	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—Barrett's esophagus	8.34e-06	0.00029	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	6.56e-06	0.000228	CbGpPWpGaD
